Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/26 18:08 | 3/2/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Davidson Michael H. | P7 | DO | CEO | 4 | S.dm | -25,328 | 32.73 | 0 | -774 | 460 | D | |||||||||||||||
2/24/26 16:40 | 2/20/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Kastelein Johannes Jacob Pieter | P7 | DO | Chief Sc | 3 | S.dm | -4,277 | 28.24 | 0 | -151 | 99 | D | |||||||||||||||
1/29/26 16:40 | 1/27/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Kooij Louise Frederika | P7 | O | Chief Ac | 8 | S.dm | -17,625 | 28.47 | 0 | -619 | 24 | D | |||||||||||||||
1/22/26 17:24 | 1/20/26 | NAMS | Health | Drug | Pharmaceutical Preparations | Somaiya Mayur Ian | P7 | O | CFO | 3 | S.dm | -3,431 | 20.54 | 0 | -167 | 58 | D | |||||||||||||||
7/17/25 17:19 | 7/15/25 | NAMS | Health | Drug | Pharmaceutical Preparations | Kling Douglas F | P7 | O | COO | 9 | S.dm | -4,026 | 4.94 | 0 | -815 | 44 | D | |||||||||||||||
1/2/25 16:15 | 12/30/24 | NAMS | Health | Drug | Pharmaceutical Preparations | Forgrowth Nap B.V. | P7 | T | 9 | S.m | -30,021 | 25.54 | 0 | -1,175 | 11,821 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |